Cannabidiol (CBD), a naturally occurring compound, possess anti-inflammatory properties that may help reduce brain ...

The Cannabidiol Market is estimated to be valued at USD 9.46 Bn in 2025 and is expected to reach USD 27.57 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 16.5% from 2025 to 2032. The ...

(Reuters) -Shares of pot companies rose on Monday after U.S. President Donald Trump advocated the potential benefits from the use of cannabidiol in senior healthcare in a social media post.

In Toronto, Charlotte's Web's shares jumped 78% to C$0.24, widening the advance in 2025 to 92%. Tilray Brands was 39% higher at C$2.24, Aurora Cannabis was ahead 30% at C$8.81, Curaleaf climbed 23% to ...

The growing cannabis legalization has translated into an increased awareness of the plant’s medicinal properties. More people are now talking about marijuana than before, an excellent development for ...

Though there is limited research on CBD, some small studies have found that it can help with anxiety, addiction, and epilepsy ...

Preclinical evidence points to CBD’s ability to curb overeating, improve metabolic health, and reduce inflammation, but researchers stress that larger, well-controlled human studies are essential ...

Shares of Tilray Brands (NASDAQ: TLRY) declined as much as 12.4% on Tuesday, but were down about 9% as of 10:30 a.m. ET. The ...

Mints market is experiencing steady growth, driven by strong consumer demand for natural ingredients and refreshing flavors.

Canada's main stock index rose to another record high on Monday, as technology shares climbed and investors who are upbeat on prospects for the global economy cheered the index's heavy weighting in ...

Goodrays was founded by CBD industry expert Eoin Keenan in 2020 and has raised over £9m in its bid to become a functional ...

Pfizer strikes MFN deal with White House as part of TrumpRx launch; FDA to be “exempt” from government shutdown; Indivior has stopped marketing Opvee.